Grant opportunity · PAR-25-336
Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)
Who can apply (as listed)
- Others (see the opportunity text)
- For-profit organizations (other than small businesses)
- Independent school districts
- Special district governments
- State governments
- Nonprofits with 501(c)(3) status (other than institutions of higher education)
- Small businesses
- Nonprofits without 501(c)(3) status (other than institutions of higher education)
- Public and state-controlled institutions of higher education
- Public housing authorities / Indian housing authorities
- Private institutions of higher education
- Native American tribal organizations (other than federally recognized governments)
- City or township governments
- County governments
- Native American tribal governments (federally recognized)
Through this Notice of Funding Opportunity (NOFO), entitled "Toward Translation of Nanotechnology Cancer Interventions" (TTNCI), the National Cancer Institute (NCI) encourages applications for advanced pre-clinical research, supporting translation of nanotechnology-based cancer diagnostics and therapeutics. TTNCI awards are designed to mature experimental nanomedicines relying on nanoparticles and nano-devices which demonstrate strong potential to improve cancer treatment effectiveness due to the combination of nanoparticle/nano-device structural design and/or therapeutic/diagnostic cargo which is delivered. TTNCI awards are expected to enable further development of proposed nanotechnology-based interventions to the stage in which they could continue on a developmental path towards the NCI Experimental Therapeutics (NExT) and other NCI translational programs.
Excerpt as published. The full synopsis, required forms, and any amendments are on the official listing.
GrantSet indexes public records and is not the official application channel. Responses and applications go through Grants.gov only — the official notice there controls if anything shown here differs.